Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2013

Jun 18, 2013

33819_dirs_2013-06-17_6a6938a8-890f-47e9-a90e-7cd4f7933f63.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2013-06-06

Reporting Person: Salinas Eliseo Oreste (EVP and Head of R&D)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-06-06 Common Stock A 390000 $0.00 Acquired 390000 Direct

Footnotes

F1: Restricted stock units, with 1/4 vesting on June 6, 2014, June 6, 2015, June 6, 2016, and June 6, 2017.

F2: Consists of 390,000 restricted stock units, with 97,500 vesting on each of June 6, 2014, June 6, 2015, June 6, 2016, and June 6, 2017.